Logo image of AMBO

AMBOW EDUCATION HOLDING-ADR (AMBO) Stock Fundamental Analysis

NYSEARCA:AMBO - NYSE Arca - US02322P3091 - ADR - Currency: USD

2.29  -0.03 (-1.29%)

Fundamental Rating

2

Overall AMBO gets a fundamental rating of 2 out of 10. We evaluated AMBO against 71 industry peers in the Diversified Consumer Services industry. The financial health of AMBO is average, but there are quite some concerns on its profitability. AMBO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year AMBO has reported negative net income.
AMBO had a positive operating cash flow in the past year.
AMBO had negative earnings in 4 of the past 5 years.
AMBO had negative operating cash flow in 4 of the past 5 years.
AMBO Yearly Net Income VS EBIT VS OCF VS FCFAMBO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M -20M -30M

1.2 Ratios

The Return On Assets of AMBO (-18.07%) is worse than 63.38% of its industry peers.
AMBO has a Return On Equity of -47.79%. This is in the lower half of the industry: AMBO underperforms 60.56% of its industry peers.
Industry RankSector Rank
ROA -18.07%
ROE -47.79%
ROIC N/A
ROA(3y)-24.07%
ROA(5y)-17.55%
ROE(3y)-77.81%
ROE(5y)-67.24%
ROIC(3y)N/A
ROIC(5y)N/A
AMBO Yearly ROA, ROE, ROICAMBO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150

1.3 Margins

AMBO has a worse Gross Margin (27.22%) than 67.61% of its industry peers.
AMBO's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for AMBO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y30.69%
GM growth 5Y-5.64%
AMBO Yearly Profit, Operating, Gross MarginsAMBO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 -60 -80

More info and screens

5

2. Health

2.1 Basic Checks

AMBO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AMBO has been increased compared to 1 year ago.
Compared to 5 years ago, AMBO has more shares outstanding
The debt/assets ratio for AMBO is higher compared to a year ago.
AMBO Yearly Shares OutstandingAMBO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M 2M 2.5M
AMBO Yearly Total Debt VS Total AssetsAMBO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of -40.28, we must say that AMBO is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of AMBO (-40.28) is worse than 87.32% of its industry peers.
The Debt to FCF ratio of AMBO is 1.32, which is an excellent value as it means it would take AMBO, only 1.32 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.32, AMBO belongs to the top of the industry, outperforming 83.10% of the companies in the same industry.
A Debt/Equity ratio of 0.41 indicates that AMBO is not too dependend on debt financing.
AMBO has a Debt to Equity ratio (0.41) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF 1.32
Altman-Z -40.28
ROIC/WACCN/A
WACC9.7%
AMBO Yearly LT Debt VS Equity VS FCFAMBO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M 30M

2.3 Liquidity

AMBO has a Current Ratio of 1.65. This is a normal value and indicates that AMBO is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.65, AMBO is doing good in the industry, outperforming 61.97% of the companies in the same industry.
AMBO has a Quick Ratio of 1.64. This is a normal value and indicates that AMBO is financially healthy and should not expect problems in meeting its short term obligations.
AMBO has a Quick ratio of 1.64. This is in the better half of the industry: AMBO outperforms 66.20% of its industry peers.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 1.64
AMBO Yearly Current Assets VS Current LiabilitesAMBO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

0

3. Growth

3.1 Past

AMBO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.06%, which is quite impressive.
Looking at the last year, AMBO shows a very negative growth in Revenue. The Revenue has decreased by -39.76% in the last year.
AMBO shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -35.23% yearly.
EPS 1Y (TTM)98.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%101.22%
Revenue 1Y (TTM)-39.76%
Revenue growth 3Y-19.27%
Revenue growth 5Y-35.23%
Sales Q2Q%-12.06%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AMBO Yearly Revenue VS EstimatesAMBO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
AMBO Yearly EPS VS EstimatesAMBO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AMBO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AMBO Price Earnings VS Forward Price EarningsAMBO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, AMBO is valued cheaply inside the industry as 98.59% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 3.18
EV/EBITDA N/A
AMBO Per share dataAMBO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AMBO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMBOW EDUCATION HOLDING-ADR

NYSEARCA:AMBO (3/7/2025, 8:04:43 PM)

2.29

-0.03 (-1.29%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)04-01 2024-04-01/amc
Earnings (Next)N/A N/A
Inst Owners0%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap6.50M
Analysts0
Price TargetN/A
Short Float %1.96%
Short Ratio0.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.71
P/FCF 3.18
P/OCF 3.18
P/B 0.98
P/tB 1.06
EV/EBITDA N/A
EPS(TTM)-1.14
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.72
FCFY31.44%
OCF(TTM)0.72
OCFY31.44%
SpS3.23
BVpS2.34
TBVpS2.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.07%
ROE -47.79%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.22%
FCFM 22.29%
ROA(3y)-24.07%
ROA(5y)-17.55%
ROE(3y)-77.81%
ROE(5y)-67.24%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y30.69%
GM growth 5Y-5.64%
F-Score6
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF 1.32
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.65
Quick Ratio 1.64
Altman-Z -40.28
F-Score6
WACC9.7%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%101.22%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-39.76%
Revenue growth 3Y-19.27%
Revenue growth 5Y-35.23%
Sales Q2Q%-12.06%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y52.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y141.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y139.62%
OCF growth 3YN/A
OCF growth 5YN/A